Molina Healthcare’s (MOH) “Neutral” Rating Reiterated at JPMorgan Chase & Co.

JPMorgan Chase & Co. reaffirmed their neutral rating on shares of Molina Healthcare (NYSE:MOH) in a research report sent to investors on Tuesday, Marketbeat Ratings reports. JPMorgan Chase & Co. currently has a $350.00 target price on the stock, down from their prior target price of $378.00.

MOH has been the subject of a number of other research reports. Robert W. Baird reduced their price target on Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Wells Fargo & Company increased their target price on shares of Molina Healthcare from $360.00 to $362.00 and gave the company an “equal weight” rating in a research report on Monday, November 4th. Barclays raised their target price on shares of Molina Healthcare from $359.00 to $372.00 and gave the company an “equal weight” rating in a research note on Friday, October 25th. StockNews.com raised shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, October 18th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 price objective on shares of Molina Healthcare in a research note on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $363.42.

Molina Healthcare Stock Down 1.0 %

Molina Healthcare stock opened at $293.52 on Tuesday. The firm has a market capitalization of $16.79 billion, a P/E ratio of 14.91, a P/E/G ratio of 1.03 and a beta of 0.54. The company has a 50-day simple moving average of $307.34 and a 200-day simple moving average of $318.83. Molina Healthcare has a one year low of $272.69 and a one year high of $423.92. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.55 and a current ratio of 1.54.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, October 23rd. The company reported $6.01 EPS for the quarter, beating the consensus estimate of $5.96 by $0.05. The company had revenue of $10.34 billion for the quarter, compared to analyst estimates of $9.92 billion. Molina Healthcare had a net margin of 2.92% and a return on equity of 27.88%. Molina Healthcare’s revenue was up 21.0% compared to the same quarter last year. During the same quarter last year, the business earned $5.05 earnings per share. As a group, equities analysts expect that Molina Healthcare will post 23.44 earnings per share for the current year.

Institutional Investors Weigh In On Molina Healthcare

Large investors have recently modified their holdings of the stock. True Wealth Design LLC lifted its holdings in shares of Molina Healthcare by 2,500.0% during the third quarter. True Wealth Design LLC now owns 104 shares of the company’s stock valued at $36,000 after purchasing an additional 100 shares during the last quarter. Innealta Capital LLC purchased a new stake in Molina Healthcare during the second quarter valued at about $36,000. Ashton Thomas Private Wealth LLC acquired a new position in shares of Molina Healthcare in the second quarter worth about $40,000. Capital Performance Advisors LLP purchased a new position in shares of Molina Healthcare in the third quarter worth approximately $62,000. Finally, AM Squared Ltd acquired a new stake in shares of Molina Healthcare during the second quarter valued at approximately $59,000. 98.50% of the stock is owned by institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.